A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Clinical trial NCT07738614 · RECRUITING
Trial details
- NCT number
- NCT07738614
- Sponsor
- Eli Lilly and Company
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-31
- Primary completion
- 2026-12-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.